GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
6KKU | Q9UP95 | human KCC1 structure determined in NaCl and GDN | Solute carrier family 12 member 4 |
6IRT | J3KPF3 | human LAT1-4F2hc complex bound with BCH | 4F2 cell-surface antigen heavy chain, Large neutral amino acids transporter small subunit 1 |
6IRT | Q01650 | human LAT1-4F2hc complex bound with BCH | 4F2 cell-surface antigen heavy chain, Large neutral amino acids transporter small subunit 1 |
6IRS | J3KPF3 | human LAT1-4F2hc complex incubated with JPH203 | 4F2 cell-surface antigen heavy chain, Large neutral amino acids transporter small subunit 1 |
6IRS | Q01650 | human LAT1-4F2hc complex incubated with JPH203 | 4F2 cell-surface antigen heavy chain, Large neutral amino acids transporter small subunit 1 |
6GKD | Q20BJ8 | human NBD1 of CFTR in complex with nanobodies D12 and G3a | Cystic fibrosis transmembrane conductance regulator (E.C.3.6.3.49), Nanobody T27 |
6GKD | 6GKD | human NBD1 of CFTR in complex with nanobodies D12 and G3a | Cystic fibrosis transmembrane conductance regulator (E.C.3.6.3.49), Nanobody T27 |
4D4J | Q16875 | human PFKFB3 in complex with a pyrrolopyrimidone compound | |
4D4K | Q16875 | human PFKFB3 in complex with a pyrrolopyrimidone compound | |
4D4L | Q16875 | human PFKFB3 in complex with a pyrrolopyrimidone compound | |
4D4M | Q16875 | human PFKFB3 in complex with a pyrrolopyrimidone compound | |
6D1W | Q13563 | human PKD2 F604P mutant | Polycystin-2 |
4B2D | P14618 | human PKM2 with L-serine and FBP bound. | |
5L0V | Q8NBL1 | human POGLUT1 in complex with 2F-glucose modified EGF(+) and UDP | Protein O-glucosyltransferase 1 (E.C.2.4.1.-,2.4.2.26), EGF(+) |
5L0V | 5L0V | human POGLUT1 in complex with 2F-glucose modified EGF(+) and UDP | Protein O-glucosyltransferase 1 (E.C.2.4.1.-,2.4.2.26), EGF(+) |
5L0T | Q8NBL1 | human POGLUT1 in complex with EGF(+) and UDP | Protein O-glucosyltransferase 1 (E.C.2.4.1.-,2.4.2.26), EGF(+) |
5L0T | 5L0T | human POGLUT1 in complex with EGF(+) and UDP | Protein O-glucosyltransferase 1 (E.C.2.4.1.-,2.4.2.26), EGF(+) |
5L0U | Q8NBL1 | human POGLUT1 in complex with EGF(+) and UDP-phosphono-glucose | Protein O-glucosyltransferase 1 (E.C.2.4.1.-,2.4.2.26), EGF(+) |
5L0U | 5L0U | human POGLUT1 in complex with EGF(+) and UDP-phosphono-glucose | Protein O-glucosyltransferase 1 (E.C.2.4.1.-,2.4.2.26), EGF(+) |
5L0S | Q8NBL1 | human POGLUT1 in complex with Factor VII EGF1 and UDP | Protein O-glucosyltransferase 1 (E.C.2.4.1.-,2.4.2.26), Coagulation factor VII (E.C.3.4.21.21) |
5L0S | P08709 | human POGLUT1 in complex with Factor VII EGF1 and UDP | Protein O-glucosyltransferase 1 (E.C.2.4.1.-,2.4.2.26), Coagulation factor VII (E.C.3.4.21.21) |
5L0R | Q8NBL1 | human POGLUT1 in complex with Notch1 EGF12 and UDP | Protein O-glucosyltransferase 1 (E.C.2.4.1.-,2.4.2.26), Neurogenic locus notch homolog protein 1 |
5L0R | P46531 | human POGLUT1 in complex with Notch1 EGF12 and UDP | Protein O-glucosyltransferase 1 (E.C.2.4.1.-,2.4.2.26), Neurogenic locus notch homolog protein 1 |
5UB5 | Q8NBL1 | human POGLUT1 in complex with human Notch1 EGF12 S458T mutant and UDP | |
5UB5 | P46531 | human POGLUT1 in complex with human Notch1 EGF12 S458T mutant and UDP | |
1U4L | P13501 | human RANTES complexed to heparin-derived disaccharide I-S | |
1U4M | P13501 | human RANTES complexed to heparin-derived disaccharide III-S | |
4GNC | Q15493 | human SMP30/GNL-1,5-AG complex | |
6HCY | Q687X5 | human STEAP4 bound to NADP, FAD, heme and Fe(III)-NTA. | Metalloreductase STEAP4 (E.C.1.16.1.-) |
6HD1 | Q687X5 | human STEAP4 bound to NADPH, FAD and heme. | Metalloreductase STEAP4 (E.C.1.16.1.-) |
7BAO | Q6N022 | human Teneurin4 Mut C1 | |
7BAN | Q6N022 | human Teneurin4 Mut C2 | |
7BAM | Q6N022 | human Teneurin4 WT C2 | |
4V2A | Q6ZN44 | human Unc5A ectodomain | NETRIN RECEPTOR UNC5A |
1OGS | P04062 | human acid-beta-glucosidase | GLUCOSYLCERAMIDASE (E.C.3.2.1.45) |
7EKP | P36544 | human alpha 7 nicotinic acetylcholine receptor bound to EVP-6124 | Neuronal acetylcholine receptor subunit alpha-7 |
7EKT | P36544 | human alpha 7 nicotinic acetylcholine receptor bound to EVP-6124 and PNU-120596 | Neuronal acetylcholine receptor subunit alpha-7 |
7EKI | P36544 | human alpha 7 nicotinic acetylcholine receptor in apo-form | Neuronal acetylcholine receptor subunit alpha-7 |
8C9X | P36544 | human alpha7 nicotinic receptor in complex with the C4 nanobody | |
8C9X | 8C9X | human alpha7 nicotinic receptor in complex with the C4 nanobody | |
8CAU | P36544 | human alpha7 nicotinic receptor in complex with the C4 nanobody and nicotine | |
8CAU | 8CAU | human alpha7 nicotinic receptor in complex with the C4 nanobody and nicotine | |
8CI2 | P36544 | human alpha7 nicotinic receptor in complex with the C4 nanobody under sub-saturating conditions | |
8CI2 | 8CI2 | human alpha7 nicotinic receptor in complex with the C4 nanobody under sub-saturating conditions | |
6Q0O | 6Q0O | human antibody H2227 lineage 652 in complex with influenza hemagglutinin head domain of A/Solomon Islands/3/2006(H1N1) | Hemagglutinin head domain, H2227 Fab lambda chain, H2227 Fab heavy chain |
3CU0 | O94766 | human beta 1,3-glucuronyltransferase I (GlcAT-I) in complex with UDP and GAL-GAL(6-SO4)-XYL(2-PO4)-O-SER | |
7BGC | P06276 | human butyrylcholinesterase in complex with a tacrine-methylanacardate hybrid inhibitor | |
6RU5 | P01024 | human complement C3 in complex with the hC3Nb1 nanobody | |
6RU5 | 6RU5 | human complement C3 in complex with the hC3Nb1 nanobody | |
6DFX | Q30069 | human diabetogenic TCR T1D3 in complex with DQ8-p8E9E peptide | MHC class II HLA-DQ-alpha chain, MHC class II antigen, T1D3 alpha chain, T1D3 beta chain |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024